A Deadline is coming up on May 24, 2022, in the lawsuit for certain investors in Homology Medicines, Inc. (NASDAQ:FIXX).
San Diego, CA -- (SBWIRE) -- 05/24/2022 -- The Shareholders Foundation announced that a deadline is coming up on May 24, 2022, in the lawsuit filed for certain investors of Homology Medicines, Inc. (NASDAQ: FIXX).
Investors who purchased shares of Homology Medicines, Inc. (NASDAQ: FIXX) have certain options and there are strict and short deadlines running. Deadline: May 24, 2022. NASDAQ: FIXX stockholders should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Homology Medicines, Inc. (NASDAQ: FIXX) common shares between June 10, 2019 and February 18, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between June 10, 2019 and February 18, 2022, the Defendants made false and/or misleading statements and/or failed to disclose that the Company had overstated HMI-102's efficacy and risk mitigation, that accordingly, it was unlikely that the Company would be able to commercialize HMI-102 in its present form, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Homology Medicines, Inc. (NASDAQ: FIXX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.